학술논문
Single-dose infliximab in hepatitis C genotype 1 treatmentnaive patients with high serum levels of tumour necrosis factor-alpha does not influence the efficacy of pegylated interferon alpha-2b/ribavirin therapy.
Document Type
Article
Author
Source
Canadian Journal of Gastroenterology & Hepatology; 2014, Vol. 28 Issue 1, p35-40, 6p
Subject
Language
ISSN
22912789